The investigators performed the present study to evaluate the role of proton beam therapy for liver metastasis which is unresectable and unsuitable for radiofrequency ablation (RFA) in terms of local control and safety.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
66
Proton beam radiotherapy 70 gray relative biological equivalent (GyRBE)/10 fractions (Fx) or 60 GyRBE/5 Fx
Samsung Medical Center
Seoul, South Korea
6 month local control rate
local control rate (except local progression)
Time frame: at the point of 6 month follow-up after proton beam therapy
Overall survival rate
overall survival rate
Time frame: at the point of 2 year follow-up after proton beam therapy
6 month side effect
side effect
Time frame: at the point of 6 month follow-up after proton beam therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.